GLUCOCORTICOSTEROID THERAPY AND PHYSICAL DEVELOPMENTOF CHILDREN WITH STEROID-SENSITIVE NEPHROTIC SYNDROME: A RETROSPECTIVE STUDY
Background. Body weight gain and growth retardation are common side effects of prolonged glucocorticosteroid therapy in children. Time for the appearance and elimination of glucocorticosteroid obesity as well as growth disorders require further investigations.Objective. Our aim was to study th...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
"Paediatrician" Publishers LLC
2017-09-01
|
| Series: | Вопросы современной педиатрии |
| Subjects: | |
| Online Access: | https://vsp.spr-journal.ru/jour/article/view/1788 |
| _version_ | 1826561773871824896 |
|---|---|
| author | Olga A. Zhdanova |
| author_facet | Olga A. Zhdanova |
| author_sort | Olga A. Zhdanova |
| collection | DOAJ |
| description | Background. Body weight gain and growth retardation are common side effects of prolonged glucocorticosteroid therapy in children. Time for the appearance and elimination of glucocorticosteroid obesity as well as growth disorders require further investigations.Objective. Our aim was to study the relationship between glucocorticosteroid therapy and changes in physical development indices of children with steroid-sensitive nephrotic syndrome (SSNS).Methods. We carried out a retrospective study of case records of patients with SSNS hospitalized in 2011–2014. Treatment of children was carried out in accordance with the Federal Clinical Guidelines. The Z-score (ANTHRO Plus) was determined for body length (height), body weight, body mass index and correlation of physical development indices with a cumulative dose and duration of glucocorticosteroid therapy.Results. We analyzed data on the treatment of 31 children, 18 of them received glucocorticosteroids for 6 months (Group 1), 13 of them did not receive glucocorticosteroids 6 months (Group 2). The Z-score of body weight in children in these groups was 1.64 ± 1.54 and 0.05 ± 1.19 (p = 0.004), Z-score of body mass index was 1.85 ± 1.64 and -0.54 ± 1.14, respectively (p < 0.001). Excess body weight and obesity were only observed in children of Group 1 (in 6 and 9, respectively). The Z-score of the body length of patients in groups 1 and 2 were comparable and did not differ from normal values (0.34 ± 1.08 and 0.52 ± 1.12, respectively, p = 0.655). Correlation of Z-score values of the body length and cumulative doses of glucocorticosteroids was noted (r = -0.87, p < 0.001).Conclusion. Long-term (at least 6 months) glucocorticosteroid intake is associated with the development of overweight and obesity in most children with SSNS. In patients who did not use hormonal drugs for 6 months, normal body weight values were recorded. The height of children with SSNS was within the range of normal values. |
| first_indexed | 2024-03-12T04:47:33Z |
| format | Article |
| id | doaj.art-024fffe647604634a82e048ec972951d |
| institution | Directory Open Access Journal |
| issn | 1682-5527 1682-5535 |
| language | English |
| last_indexed | 2025-03-14T09:37:31Z |
| publishDate | 2017-09-01 |
| publisher | "Paediatrician" Publishers LLC |
| record_format | Article |
| series | Вопросы современной педиатрии |
| spelling | doaj.art-024fffe647604634a82e048ec972951d2025-03-02T11:34:20Zeng"Paediatrician" Publishers LLCВопросы современной педиатрии1682-55271682-55352017-09-0116429129610.15690/vsp.v16i4.17751694GLUCOCORTICOSTEROID THERAPY AND PHYSICAL DEVELOPMENTOF CHILDREN WITH STEROID-SENSITIVE NEPHROTIC SYNDROME: A RETROSPECTIVE STUDYOlga A. Zhdanova0Voronezh State Medical University named after N.N. BurdenkoBackground. Body weight gain and growth retardation are common side effects of prolonged glucocorticosteroid therapy in children. Time for the appearance and elimination of glucocorticosteroid obesity as well as growth disorders require further investigations.Objective. Our aim was to study the relationship between glucocorticosteroid therapy and changes in physical development indices of children with steroid-sensitive nephrotic syndrome (SSNS).Methods. We carried out a retrospective study of case records of patients with SSNS hospitalized in 2011–2014. Treatment of children was carried out in accordance with the Federal Clinical Guidelines. The Z-score (ANTHRO Plus) was determined for body length (height), body weight, body mass index and correlation of physical development indices with a cumulative dose and duration of glucocorticosteroid therapy.Results. We analyzed data on the treatment of 31 children, 18 of them received glucocorticosteroids for 6 months (Group 1), 13 of them did not receive glucocorticosteroids 6 months (Group 2). The Z-score of body weight in children in these groups was 1.64 ± 1.54 and 0.05 ± 1.19 (p = 0.004), Z-score of body mass index was 1.85 ± 1.64 and -0.54 ± 1.14, respectively (p < 0.001). Excess body weight and obesity were only observed in children of Group 1 (in 6 and 9, respectively). The Z-score of the body length of patients in groups 1 and 2 were comparable and did not differ from normal values (0.34 ± 1.08 and 0.52 ± 1.12, respectively, p = 0.655). Correlation of Z-score values of the body length and cumulative doses of glucocorticosteroids was noted (r = -0.87, p < 0.001).Conclusion. Long-term (at least 6 months) glucocorticosteroid intake is associated with the development of overweight and obesity in most children with SSNS. In patients who did not use hormonal drugs for 6 months, normal body weight values were recorded. The height of children with SSNS was within the range of normal values.https://vsp.spr-journal.ru/jour/article/view/1788childrennephrotic syndromeglucocorticosteroidsbody lengthbody weightobesity |
| spellingShingle | Olga A. Zhdanova GLUCOCORTICOSTEROID THERAPY AND PHYSICAL DEVELOPMENTOF CHILDREN WITH STEROID-SENSITIVE NEPHROTIC SYNDROME: A RETROSPECTIVE STUDY Вопросы современной педиатрии children nephrotic syndrome glucocorticosteroids body length body weight obesity |
| title | GLUCOCORTICOSTEROID THERAPY AND PHYSICAL DEVELOPMENTOF CHILDREN WITH STEROID-SENSITIVE NEPHROTIC SYNDROME: A RETROSPECTIVE STUDY |
| title_full | GLUCOCORTICOSTEROID THERAPY AND PHYSICAL DEVELOPMENTOF CHILDREN WITH STEROID-SENSITIVE NEPHROTIC SYNDROME: A RETROSPECTIVE STUDY |
| title_fullStr | GLUCOCORTICOSTEROID THERAPY AND PHYSICAL DEVELOPMENTOF CHILDREN WITH STEROID-SENSITIVE NEPHROTIC SYNDROME: A RETROSPECTIVE STUDY |
| title_full_unstemmed | GLUCOCORTICOSTEROID THERAPY AND PHYSICAL DEVELOPMENTOF CHILDREN WITH STEROID-SENSITIVE NEPHROTIC SYNDROME: A RETROSPECTIVE STUDY |
| title_short | GLUCOCORTICOSTEROID THERAPY AND PHYSICAL DEVELOPMENTOF CHILDREN WITH STEROID-SENSITIVE NEPHROTIC SYNDROME: A RETROSPECTIVE STUDY |
| title_sort | glucocorticosteroid therapy and physical developmentof children with steroid sensitive nephrotic syndrome a retrospective study |
| topic | children nephrotic syndrome glucocorticosteroids body length body weight obesity |
| url | https://vsp.spr-journal.ru/jour/article/view/1788 |
| work_keys_str_mv | AT olgaazhdanova glucocorticosteroidtherapyandphysicaldevelopmentofchildrenwithsteroidsensitivenephroticsyndromearetrospectivestudy |